Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

First Wave BioPharma, Inc. FWBI

Full chart Compare
Set alert

Price alert · FWBI

All alert types
2.96 +2.96

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-9.94 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2016: -42.3×FY 2017: -69.7×FY 2018: -27.6×FY 2019: -1.5×FY 2020: -0.7×FY 2021: -0.2×FY 2022: -0.3×FY 2023: -0.1×FY 2024: -0.5×FY 2025: -0.7×
FY 2016 5y median -0.3× FY 2025
P/S 126×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 126×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016: 192×FY 2017: 466×FY 2018: 83.5×FY 2019: 5.1×FY 2020: -10.4×FY 2021: -1.6×FY 2022: 1.6×FY 2023: 0.4×FY 2024: -2.5×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
P/FCF -0.8×
FY 2016: -136×FY 2017: -107×FY 2018: -34.2×FY 2019: -1.7×FY 2020: -2.5×FY 2021: -0.3×FY 2022: -0.2×FY 2023: -0.1×FY 2024: -1.1×FY 2025: -0.8×
FY 2016 5y median -0.3× FY 2025
EV/EBITDA 10.2×
FY 2016: -104×FY 2017: -82.9×FY 2018: -29.5×FY 2019: -1.8×FY 2020: -0.8×FY 2021: -0.1×FY 2022: -0.3×FY 2023: 0.1×FY 2024: 198×FY 2025: 10.2×
FY 2016 5y median 0.1× FY 2025
EV/Sales 161×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 161×
FY 2016 5y median 0.0× FY 2025
FCF Yield -124.6%
FY 2016: -0.7%FY 2017: -0.9%FY 2018: -2.9%FY 2019: -60.3%FY 2020: -40.7%FY 2021: -330.4%FY 2022: -507.3%FY 2023: -911.6%FY 2024: -94.8%FY 2025: -124.6%
FY 2016 5y median -330.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin -19540.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -19540.0%
FY 2016 5y median 0.0% FY 2025
Net Margin -18078.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -18078.3%
FY 2016 5y median 0.0% FY 2025
ROE -26.3%
FY 2016: -454.1%FY 2017: -668.2%FY 2018: -302.5%FY 2019: -338.1%FY 2020: 1466.4%FY 2021: 755.3%FY 2022: -604.7%FY 2023: -438.4%FY 2024: 465.8%FY 2025: -26.3%
FY 2016 5y median -26.3% FY 2025
ROIC -19.9%
FY 2016: -138.5%FY 2017: -299.1%FY 2018: -281.8%FY 2019: -237.0%FY 2020: 1313.9%FY 2021: -28282.2%FY 2022: -349.7%FY 2023: -356.0%FY 2024: -27.0%FY 2025: -19.9%
FY 2016 5y median -349.7% FY 2025
ROA -13.5%
FY 2016: -216.0%FY 2017: -202.5%FY 2018: -181.2%FY 2019: -175.4%FY 2020: -299.6%FY 2021: -501.1%FY 2022: -304.8%FY 2023: -229.5%FY 2024: -21.1%FY 2025: -13.5%
FY 2016 5y median -229.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 54.7%
FY 2016: -33.8%FY 2017: -61.6%FY 2018: -31.4%FY 2019: -9.8%FY 2020: -79.3%FY 2021: -123.4%FY 2022: 78.5%FY 2023: -24.4%FY 2024: 0.9%FY 2025: 54.7%
FY 2016 FY 2025
EPS (diluted) 22.0%
FY 2016: -273.4%FY 2017: 53.5%FY 2018: 16.0%FY 2019: -1488.3%FY 2020: -95.6%FY 2021: 51.4%FY 2022: 98.3%FY 2023: 89.8%FY 2024: 88.6%FY 2025: 22.0%
FY 2016 FY 2025
Free Cash Flow 38.1%
FY 2016: -0.3%FY 2017: -58.7%FY 2018: -51.4%FY 2019: -28.7%FY 2020: 20.1%FY 2021: -279.6%FY 2022: 47.6%FY 2023: 42.4%FY 2024: 28.4%FY 2025: 38.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.2×
FY 2016: 1.3×FY 2017: 0.8×FY 2018: 1.6×FY 2019: 0.8×FY 2020: 0.5×FY 2021: 0.8×FY 2022: 1.4×FY 2023: 1.6×FY 2024: 3.0×FY 2025: 0.2×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 0.2×
FY 2016: 1.3×FY 2017: 0.8×FY 2018: 1.6×FY 2019: 0.8×FY 2020: 0.5×FY 2021: 0.8×FY 2022: 1.4×FY 2023: 1.6×FY 2024: 3.0×FY 2025: 0.2×
FY 2016 5y median 1.4× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.3×FY 2018: 0.1×FY 2019: 0.3×FY 2020: -0.2×FY 2021: -0.1×FY 2022: 0.3×FY 2023: 0.2×FY 2024: -0.0×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 2.2×
FY 2016: 0.3×FY 2017: 0.0×FY 2018: 0.1×FY 2019: -0.1×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.2×FY 2024: -0.5×FY 2025: 2.2×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 14.4×
FY 2016: -1.1×FY 2017: -11.7×FY 2018: -132×FY 2019: -34.0×FY 2020: -4.5×FY 2021: -5257×FY 2022: -798×FY 2023: 0.0×FY 2024: -17853×FY 2025: 14.4×
FY 2016 5y median -798× FY 2025

Dividends

Dividend Yield 7.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 2.5%FY 2025: 7.4%
FY 2016 5y median 0.0% FY 2025
Payout Ratio -5.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1.3%FY 2025: -5.1%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31